image
Harrow Health, Inc. 8.625% Senior Notes due 2026 HROWL
Healthcare - Medical - Pharmaceuticals - NASDAQ - US
Watchlist
$ 25.3
-0.472 %
$ 1.83 B
Market Cap
None
P/E
1. INTRINSIC VALUE

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.[ Read More ]

The intrinsic value of one HROWL stock under the base case scenario is HIDDEN Compared to the current market price of 25.3 USD, Harrow Health, Inc. 8.625% Senior Notes due 2026 is HIDDEN

HROWL Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart HROWL

image
FINANCIALS
130 M REVENUE
46.95%
Growth Rates
1Year 46.95%
3Years 38.63%
5Years 25.77%
7Years 30.74%
10Years 157.90%
580 K OPERATING INCOME
133.22%
Growth Rates
1Year 133.22%
3Years 33.05%
5Years 16.12%
7Years 10.69%
10Years 7.57%
-24.4 M NET INCOME
-73.30%
Growth Rates
1Year -73.30%
3Years -92.56%
5Years -21.70%
7Years -3.58%
10Years -12.31%
3.84 M OPERATING CASH FLOW
125.22%
Growth Rates
1Year 125.22%
3Years 76.42%
5Years 41.08%
7Years 12.93%
10Years 11.10%
-153 M INVESTING CASH FLOW
-8652.32%
Growth Rates
1Year -8652.32%
3Years -437.75%
5Years -133.47%
7Years -54.41%
10Years -115.69%
127 M FINANCING CASH FLOW
133.70%
Growth Rates
1Year 133.70%
3Years 345.29%
5Years 98.26%
7Years 26.31%
10Years 28.82%
49.3 M REVENUE
0.65%
Growth Rates
1Year 46.95%
3Years 38.63%
5Years 25.77%
7Years 30.74%
10Years 157.90%
1.32 M OPERATING INCOME
-13.66%
Growth Rates
1Year 133.22%
3Years 33.05%
5Years 16.12%
7Years 10.69%
10Years 7.57%
-4.22 M NET INCOME
34.81%
Growth Rates
1Year -73.30%
3Years -92.56%
5Years -21.70%
7Years -3.58%
10Years -12.31%
2.95 M OPERATING CASH FLOW
207.47%
Growth Rates
1Year 125.22%
3Years 76.42%
5Years 41.08%
7Years 12.93%
10Years 11.10%
-597 K INVESTING CASH FLOW
-11.70%
Growth Rates
1Year -8652.32%
3Years -437.75%
5Years -133.47%
7Years -54.41%
10Years -115.69%
-721 K FINANCING CASH FLOW
-987.67%
Growth Rates
1Year 133.70%
3Years 345.29%
5Years 98.26%
7Years 26.31%
10Years 28.82%
Balance Sheet Decomposition Harrow Health, Inc. 8.625% Senior Notes due 2026
image
Current Assets 139 M
Cash & Short-Term Investments 82.8 M
Receivables 36.5 M
Other Current Assets 19.8 M
Non-Current Assets 173 M
Long-Term Investments 0
PP&E 10.3 M
Other Non-Current Assets 162 M
Current Liabilities 49.3 M
Accounts Payable 21.4 M
Short-Term Debt 806 K
Other Current Liabilities 27.1 M
Non-Current Liabilities 192 M
Long-Term Debt 190 M
Other Non-Current Liabilities 2.71 M
EFFICIENCY
Earnings Waterfall Harrow Health, Inc. 8.625% Senior Notes due 2026
image
Revenue 130 M
Cost Of Revenue 39.6 M
Gross Profit 90.6 M
Operating Expenses 90 M
Operating Income 580 K
Other Expenses 25 M
Net Income -24.4 M
RATIOS
69.55% GROSS MARGIN
69.55%
Averages
1Year 69.55%
3Years 71.92%
5Years 70.69%
7Years 66.15%
10Years 59.44%
0.45% OPERATING MARGIN
0.45%
Averages
1Year 0.45%
3Years -0.64%
5Years -1.25%
7Years -9.18%
10Years -90.76%
-18.75% NET MARGIN
-18.75%
Averages
1Year -18.75%
3Years -19.83%
5Years -14.31%
7Years -11.57%
10Years -94.98%
-34.70% ROE
-34.70%
Averages
1Year -34.70%
3Years -81.99%
5Years -53.58%
7Years -95.30%
10Years 5.99%
-7.83% ROA
-7.83%
Averages
1Year -7.83%
3Years -11.70%
5Years -9.09%
7Years -9.43%
10Years -34.73%
0.23% ROIC
0.23%
Averages
1Year 0.23%
3Years -0.48%
5Years -5.96%
7Years -17.96%
10Years -55.24%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Harrow Health, Inc. 8.625% Senior Notes due 2026
image
Net Income -24.4 M
Depreciation & Amortization 12.3 M
Capital Expenditures -153 M
Stock-Based Compensation 15.7 M
Change in Working Capital -7.14 M
Others 3.09 M
Free Cash Flow -149 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Harrow Health, Inc. 8.625% Senior Notes due 2026
image
HROWL has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.539 USD DIVIDEND PER SHARE
5. COMPETITION

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal.

image
0 USD
BWSN
Overvalued 100.00%

Babcock & Wilcox Enterprises, Inc., together with its subsidiaries, provides energy and emissions control solutions to a range of industrial, electrical utility, municipal, and other customers worldwide.

image
0 USD
BWNB
Overvalued 100.00%

B. Riley Financial, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms.

image
8.55 USD
RILYT
Overvalued 13.98%

SiriusPoint Ltd. provides multi-line insurance and reinsurance products and services worldwide. The company operates through two segments, Reinsurance, and Insurance & Services.

image
4.01 USD
SPNT-PB
Overvalued 84.11%
6. Ownership
Insider Ownership Harrow Health, Inc. 8.625% Senior Notes due 2026
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
262 K USD 2
9-12 MONTHS
Date Value Insider Amount Avg Price
1 year ago
Nov 16, 2023
Bought 60.8 K USD
BAUM MARK L
Chief Executive Officer
+ 7500
 8.11 USD
1 year ago
Nov 15, 2023
Bought 201 K USD
Opaleye Management Inc.
10 percent owner
+ 25000
 8.0294 USD
1 year ago
Sep 20, 2023
Bought 86.7 K USD
Opaleye Management Inc.
10 percent owner
+ 5983
 14.4928 USD
1 year ago
Sep 19, 2023
Bought 205 K USD
Opaleye Management Inc.
10 percent owner
+ 14017
 14.6512 USD
1 year ago
Aug 14, 2023
Bought 98.9 K USD
BAUM MARK L
Chief Executive Officer
+ 5800
 17.05 USD
1 year ago
Aug 14, 2023
Bought 338 K USD
Makary Martin A.
Director
+ 20000
 16.92 USD
1 year ago
Dec 22, 2022
Bought 335 K USD
BAUM MARK L
Chief Executive Officer
+ 25000
 13.39 USD
1 year ago
Dec 22, 2022
Bought 33.8 K USD
BOLL ANDREW R.
Chief Financial Officer
+ 2500
 13.54 USD
1 year ago
Dec 21, 2022
Bought 334 K USD
Makary Martin A.
Director
+ 25000
 13.37 USD
1 year ago
Dec 22, 2022
Bought 25 K USD
Van Horn R. Lawrence
Director
+ 1860
 13.42 USD
1 year ago
Dec 14, 2022
Bought 4.37 M USD
Opaleye Management Inc.
Director
+ 415000
 10.52 USD
1 year ago
Dec 14, 2022
Bought 170 K USD
Opaleye Management Inc.
Director
+ 16183
 10.52 USD
2 years ago
Jan 28, 2022
Bought 34.4 K USD
Opaleye Management Inc.
10 percent owner
+ 5000
 6.8873 USD
2 years ago
Jan 28, 2022
Bought 9.25 K USD
Opaleye Management Inc.
10 percent owner
+ 1343
 6.8873 USD
3 years ago
Sep 24, 2021
Sell 39.2 K USD
LINDSTROM RICHARD L MD
Director
- 3900
 10.04 USD
3 years ago
Sep 15, 2021
Sell 129 K USD
LINDSTROM RICHARD L MD
Director
- 14160
 9.09 USD
3 years ago
Sep 16, 2021
Sell 52.7 K USD
LINDSTROM RICHARD L MD
Director
- 5840
 9.02 USD
3 years ago
Aug 19, 2021
Bought 422 K USD
Opaleye Management Inc.
10 percent owner
+ 50000
 8.445 USD
3 years ago
Aug 19, 2021
Bought 21.1 K USD
Opaleye Management Inc.
10 percent owner
+ 2500
 8.445 USD
3 years ago
Aug 18, 2021
Bought 389 K USD
Opaleye Management Inc.
10 percent owner
+ 45000
 8.6447 USD
3 years ago
Aug 17, 2021
Bought 214 K USD
Opaleye Management Inc.
10 percent owner
+ 25000
 8.5661 USD
3 years ago
Aug 18, 2021
Bought 13 K USD
Opaleye Management Inc.
10 percent owner
+ 1500
 8.6447 USD
3 years ago
Aug 17, 2021
Bought 8.57 K USD
Opaleye Management Inc.
10 percent owner
+ 1000
 8.5661 USD
3 years ago
Jul 21, 2021
Bought 34.2 K USD
Opaleye Management Inc.
10 percent owner
+ 4500
 7.5965 USD
3 years ago
Jul 20, 2021
Bought 34.6 K USD
Opaleye Management Inc.
10 percent owner
+ 4800
 7.1999 USD
3 years ago
Jul 19, 2021
Bought 39.7 K USD
Opaleye Management Inc.
10 percent owner
+ 5700
 6.9683 USD
3 years ago
Jul 21, 2021
Bought 35.7 K USD
Opaleye Management Inc.
10 percent owner
+ 4706
 7.5965 USD
3 years ago
Jul 20, 2021
Bought 900 USD
Opaleye Management Inc.
10 percent owner
+ 125
 7.1999 USD
3 years ago
Jul 19, 2021
Bought 1.18 K USD
Opaleye Management Inc.
10 percent owner
+ 169
 6.9683 USD
3 years ago
Jun 18, 2021
Bought 499 K USD
Opaleye Management Inc.
10 percent owner
+ 59800
 8.3492 USD
3 years ago
Jun 17, 2021
Bought 89.9 K USD
Opaleye Management Inc.
10 percent owner
+ 10800
 8.3201 USD
3 years ago
Jun 18, 2021
Bought 29.4 K USD
Opaleye Management Inc.
10 percent owner
+ 3522
 8.3492 USD
3 years ago
Jun 17, 2021
Bought 3.84 K USD
Opaleye Management Inc.
10 percent owner
+ 462
 8.3201 USD
3 years ago
May 20, 2021
Sell 108 K USD
LINDSTROM RICHARD L MD
Director
- 10000
 10.75 USD
3 years ago
Dec 22, 2020
Bought 82.6 K USD
Opaleye Management Inc.
10 percent owner
+ 15900
 5.1948 USD
3 years ago
Dec 21, 2020
Bought 269 K USD
Opaleye Management Inc.
10 percent owner
+ 51400
 5.2394 USD
3 years ago
Dec 18, 2020
Bought 186 K USD
Opaleye Management Inc.
10 percent owner
+ 35000
 5.3126 USD
3 years ago
Dec 22, 2020
Bought 3.41 K USD
Opaleye Management Inc.
10 percent owner
+ 657
 5.1948 USD
3 years ago
Dec 21, 2020
Bought 10.8 K USD
Opaleye Management Inc.
10 percent owner
+ 2059
 5.2394 USD
3 years ago
Dec 18, 2020
Bought 7.44 K USD
Opaleye Management Inc.
10 percent owner
+ 1400
 5.3126 USD
4 years ago
Jul 12, 2020
Bought 94.8 K USD
Opaleye Management Inc.
10 percent owner
+ 19000
 4.9886 USD
4 years ago
Jul 11, 2020
Bought 232 K USD
Opaleye Management Inc.
10 percent owner
+ 46800
 4.9556 USD
4 years ago
Jul 10, 2020
Bought 224 K USD
Opaleye Management Inc.
10 percent owner
+ 45000
 4.977 USD
4 years ago
Jul 12, 2020
Bought 9.46 K USD
Opaleye Management Inc.
10 percent owner
+ 1900
 4.9801 USD
4 years ago
Jul 09, 2020
Bought 121 K USD
Opaleye Management Inc.
10 percent owner
+ 25000
 4.84 USD
4 years ago
Jul 08, 2020
Bought 325 K USD
Opaleye Management Inc.
10 percent owner
+ 65000
 4.9943 USD
4 years ago
Jul 07, 2020
Bought 214 K USD
Opaleye Management Inc.
10 percent owner
+ 41300
 5.1815 USD
4 years ago
Jul 09, 2020
Bought 24.1 K USD
Opaleye Management Inc.
10 percent owner
+ 5000
 4.8157 USD
4 years ago
Jun 19, 2020
Bought 195 K USD
Opaleye Management Inc.
10 percent owner
+ 35000
 5.5829 USD
4 years ago
Jun 04, 2020
Bought 57.9 K USD
Opaleye Management Inc.
10 percent owner
+ 10000
 5.7861 USD
4 years ago
Jun 03, 2020
Bought 118 K USD
Opaleye Management Inc.
10 percent owner
+ 20600
 5.7431 USD
4 years ago
Jun 02, 2020
Bought 110 K USD
Opaleye Management Inc.
10 percent owner
+ 19400
 5.6876 USD
4 years ago
May 22, 2020
Bought 44.5 K USD
Opaleye Management Inc.
10 percent owner
+ 8804
 5.0527 USD
4 years ago
May 21, 2020
Bought 48.4 K USD
Opaleye Management Inc.
10 percent owner
+ 10396
 4.6555 USD
4 years ago
May 20, 2020
Bought 1.34 K USD
Opaleye Management Inc.
10 percent owner
+ 300
 4.47 USD
4 years ago
May 22, 2020
Bought 25.1 K USD
Opaleye Management Inc.
10 percent owner
+ 5000
 5.021 USD
4 years ago
May 21, 2020
Bought 940 USD
Opaleye Management Inc.
10 percent owner
+ 200
 4.6981 USD
4 years ago
May 20, 2020
Bought 5.4 K USD
Opaleye Management Inc.
10 percent owner
+ 1200
 4.4981 USD
5 years ago
Nov 11, 2019
Sell 30.9 K USD
Kammer Robert J
Director
- 6500
 4.75 USD
5 years ago
Oct 07, 2019
Sell 34.1 K USD
Kammer Robert J
Director
- 6500
 5.25 USD
5 years ago
Sep 09, 2019
Sell 36.9 K USD
Kammer Robert J
Director
- 6500
 5.67 USD
5 years ago
Aug 12, 2019
Sell 44.8 K USD
Kammer Robert J
Director
- 6500
 6.89 USD
5 years ago
Jul 15, 2019
Sell 51.4 K USD
Kammer Robert J
Director
- 6500
 7.91 USD
5 years ago
Jun 03, 2019
Sell 57.8 K USD
Kammer Robert J
Director
- 10000
 5.78 USD
5 years ago
May 01, 2019
Sell 45.7 K USD
Kammer Robert J
Director
- 10000
 4.57 USD
5 years ago
Apr 01, 2019
Sell 47.7 K USD
Kammer Robert J
Director
- 10000
 4.77 USD
5 years ago
Mar 01, 2019
Sell 69.1 K USD
Kammer Robert J
Director
- 10000
 6.91 USD
5 years ago
Feb 01, 2019
Sell 58.6 K USD
Kammer Robert J
Director
- 10000
 5.86 USD
5 years ago
Jan 02, 2019
Sell 53.3 K USD
Kammer Robert J
Director
- 10000
 5.33 USD
5 years ago
Dec 03, 2018
Sell 46.4 K USD
Kammer Robert J
Director
- 10000
 4.64 USD
6 years ago
Nov 01, 2018
Sell 42.1 K USD
Kammer Robert J
Director
- 10000
 4.21 USD
6 years ago
Oct 15, 2018
Sell 30 K USD
Kammer Robert J
Director
- 10000
 3 USD
6 years ago
Sep 04, 2018
Sell 30 K USD
Kammer Robert J
Director
- 10000
 3 USD
6 years ago
Aug 10, 2018
Sell 390 K USD
Kammer Robert J
Director
- 130000
 3 USD
7 years ago
Mar 21, 2017
Bought 93.1 K USD
Longboard Capital Advisors, LLC
+ 52000
 1.79 USD
7 years ago
Jul 17, 2017
Sell 30.5 K USD
Kammer Robert J
Director
- 10000
 3.0526 USD
7 years ago
Dec 19, 2016
Bought 179 K USD
LINDSTROM RICHARD L MD
Director
+ 100000
 1.79 USD
7 years ago
Dec 19, 2016
Bought 179 K USD
LINDSTROM RICHARD L MD
Director
+ 100000
 1.79 USD
7 years ago
Dec 19, 2016
Bought 69.8 K USD
BOLL ANDREW R.
Chief Financial Officer
+ 39000
 1.79 USD
7 years ago
Dec 19, 2016
Bought 69.8 K USD
BOLL ANDREW R.
Chief Financial Officer
+ 39000
 1.79 USD
7 years ago
Dec 19, 2016
Bought 279 K USD
BAUM MARK L
Chief Executive Officer
+ 156000
 1.79 USD
7 years ago
Dec 19, 2016
Bought 279 K USD
BAUM MARK L
Chief Executive Officer
+ 156000
 1.79 USD
8 years ago
Mar 11, 2016
Bought 162 K USD
Opaleye Management Inc.
10 percent owner
+ 45000
 3.6 USD
8 years ago
Mar 11, 2016
Bought 164 K USD
Opaleye Management Inc.
10 percent owner
+ 45000
 3.65 USD
8 years ago
Mar 11, 2016
Bought 164 K USD
Opaleye Management Inc.
10 percent owner
+ 45000
 3.65 USD
9 years ago
Jun 30, 2015
Bought 276 K USD
Opaleye Management Inc.
10 percent owner
+ 35000
 7.9 USD
9 years ago
May 18, 2015
Sell 2.4 M USD
Miloni Donald Paul
10 percent owner
- 300000
 8 USD
9 years ago
May 19, 2015
Sell 880 K USD
Miloni Donald Paul
10 percent owner
- 110000
 8.0018 USD
9 years ago
May 19, 2015
Bought 22.4 K USD
Opaleye Management Inc.
10 percent owner
+ 2801
 8 USD
12 years ago
Jan 01, 2012
Bought 571 K USD
Kammer Robert J
Chief Executive Officer
+ 856087
 0.6668 USD
12 years ago
Apr 30, 2012
Bought 286 K USD
Kammer Robert J
Chief Executive Officer
+ 48262
 5.925 USD
12 years ago
Apr 30, 2012
Bought 286 K USD
DERMASTAR INTERNATIONAL, LLC
10 percent owner
+ 48262
 5.925 USD
12 years ago
Jan 01, 2012
Bought 571 K USD
DERMASTAR INTERNATIONAL, LLC
10 percent owner
+ 856087
 0.6668 USD
12 years ago
Apr 30, 2012
Bought 286 K USD
BAUM MARK L
Chief Executive Officer
+ 48262
 5.925 USD
12 years ago
Jan 01, 2012
Bought 571 K USD
BAUM MARK L
Chief Executive Officer
+ 856087
 0.6668 USD
16 years ago
Sep 29, 2008
Bought 700 USD
Singh Juliet
CEO, Director and President
+ 500
 1.4 USD
16 years ago
Sep 26, 2008
Bought 700 USD
Singh Juliet
CEO, Director and President
+ 500
 1.4 USD
16 years ago
Sep 25, 2008
Bought 3.15 K USD
THORNLEY ANTHONY S
Director
+ 3000
 1.05 USD
16 years ago
Sep 23, 2008
Bought 3.75 K USD
THORNLEY ANTHONY S
Director
+ 3000
 1.25 USD
16 years ago
Sep 10, 2008
Bought 710 USD
THORNLEY ANTHONY S
Director
+ 500
 1.42 USD
16 years ago
Sep 03, 2008
Bought 330 USD
THORNLEY ANTHONY S
Director
+ 200
 1.65 USD
16 years ago
Sep 02, 2008
Bought 300 USD
THORNLEY ANTHONY S
Director
+ 200
 1.5 USD
16 years ago
Jun 27, 2008
Bought 7.31 K USD
THORNLEY ANTHONY S
Director
+ 4200
 1.74 USD
7. News
8. Profile Summary

Harrow Health, Inc. 8.625% Senior Notes due 2026 HROWL

image
COUNTRY US
INDUSTRY Medical - Pharmaceuticals
MARKET CAP $ 1.83 B
Dividend Yield 0.00%
Description Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
Contact Nashville, http://www.harrowinc.com
IPO Date May 7, 2021
Employees 217
Officers